Published in Psychiatry Clin Neurosci on February 01, 2007
Dopaminergic control of cognitive flexibility in humans and animals. Front Neurosci (2013) 1.28
ADHD prevalence and association with hoarding behaviors in childhood-onset OCD. Depress Anxiety (2010) 1.06
Obsessive-compulsive disorder is associated with broad impairments in executive function: A meta-analysis. Clin Psychol Sci (2015) 0.86
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Reduced cortical folding of the anterior cingulate cortex in obsessive-compulsive disorder. J Psychiatry Neurosci (2009) 0.80
Break in volition: a virtual reality study in patients with obsessive-compulsive disorder. Exp Brain Res (2013) 0.79
Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2017) 0.75
Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies. J Dev Behav Pediatr (2016) 0.75
Characterization of electrically evoked field potentials in the medial prefrontal cortex and orbitofrontal cortex of the rat: modulation by monoamines. Eur Neuropsychopharmacol (2013) 0.75
Effects of Insula Resection on Autonomic Nervous System Activity. J Neurosurg Anesthesiol (2016) 2.07
Active stimulation site of nucleus accumbens deep brain stimulation in obsessive-compulsive disorder is localized in the ventral internal capsule. Acta Neurochir Suppl (2013) 2.06
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry (2005) 1.80
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry (2004) 1.57
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol (2003) 1.36
Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord (2006) 1.26
Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry (2007) 1.22
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol (2009) 1.16
Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr Res (2003) 1.15
Thinner prefrontal cortex in veterans with posttraumatic stress disorder. Neuroimage (2008) 1.12
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.12
Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet (2010) 1.10
Wireless implantable micro-stimulation device for high frequency bilateral deep brain stimulation in freely moving mice. J Neurosci Methods (2012) 1.06
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry (2005) 1.05
Glutamate and anxiety. Eur Neuropsychopharmacol (2004) 1.05
The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry (2004) 1.04
Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res (2007) 1.04
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03
Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry (2002) 1.02
Finding suitable phenotypes for genetic studies of schizophrenia: heritability and segregation analysis. Biol Psychiatry (2008) 1.01
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res (2004) 0.98
Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation? Psychiatry Res (2002) 0.98
Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. Int Clin Psychopharmacol (2006) 0.98
Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS One (2012) 0.94
Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biol Psychiatry (2008) 0.94
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology (2004) 0.93
Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol (2008) 0.92
Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology (2012) 0.92
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol (2003) 0.92
Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry (2005) 0.91
Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophr Res (2003) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Precuneal activity during encoding in veterans with posttraumatic stress disorder. Prog Brain Res (2008) 0.90
Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram. Nephrol Dial Transplant (2006) 0.89
Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders. Schizophr Bull (2004) 0.89
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry (2007) 0.88
Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl) (2003) 0.88
Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol (2006) 0.87
Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder. Cogn Neuropsychiatry (2006) 0.87
Long-term memory deficits in schizophrenia: primary or secondary dysfunction? Neuropsychology (2003) 0.87
Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol Psychiatry (2006) 0.87
Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res (2005) 0.87
Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients. Int Clin Psychopharmacol (2010) 0.87
Assessment of DSM-IV personality disorders in obsessive-compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview. J Pers Disord (2003) 0.87
Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord (2004) 0.87
School performance as a premorbid marker for schizophrenia: a twin study. Schizophr Bull (2002) 0.87
A novel self-guided approach to alpha activity training. Int J Psychophysiol (2011) 0.87
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophr Res (2010) 0.86
Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr Bull (2010) 0.85
Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Rev Anticancer Ther (2010) 0.85
Human neural systems for conceptual knowledge of proper object use: a functional magnetic resonance imaging study. Cereb Cortex (2007) 0.85
Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis. Int Clin Psychopharmacol (2009) 0.84
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. J Psychopharmacol (2003) 0.84
Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing. J Neurooncol (2014) 0.83
Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas. J Int Neuropsychol Soc (2010) 0.82
Sexual pleasure in women with obsessive-compulsive disorder? J Affect Disord (2006) 0.82
Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. Eur Neuropsychopharmacol (2006) 0.82
Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients. Psychiatry Res (2004) 0.82
Brain anatomy in non-affected parents of autistic probands: a MRI study. Psychol Med (2005) 0.81
Obstructive sleep apnea in combat-related posttraumatic stress disorder: a controlled polysomnography study. Eur J Psychotraumatol (2011) 0.81
Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry (2009) 0.81
The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther (2012) 0.81
Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord (2010) 0.81
Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology (Berl) (2002) 0.81
Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats. J Psychopharmacol (2010) 0.80
Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol (2003) 0.80
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. Int J Neuropsychopharmacol (2003) 0.80
Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord (2006) 0.80
Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study. Soc Psychiatry Psychiatr Epidemiol (2013) 0.80
Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD. Eur J Psychotraumatol (2012) 0.80
Feasibility of eyes open alpha power training for mental enhancement in elite gymnasts. J Sports Sci (2014) 0.79
The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. Eur J Pharmacol (2002) 0.79
Neuropsychological performance is related to current social and occupational functioning in veterans with posttraumatic stress disorder. Depress Anxiety (2009) 0.79
Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells. Brain Res (2002) 0.79
Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study. J Clin Psychiatry (2005) 0.79
Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.79
The COMPlaints After Stroke (COMPAS) study: protocol for a Dutch cohort study on poststroke subjective cognitive complaints. BMJ Open (2013) 0.79
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol (2010) 0.79
Verbal memory in first-episode schizophrenia: heterogeneity in performance? J Int Neuropsychol Soc (2005) 0.79
Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats. Int J Neuropsychopharmacol (2006) 0.78
Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology (Berl) (2003) 0.78
Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res (2008) 0.78
Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. Int Clin Psychopharmacol (2005) 0.78
Global intellectual impairment does not accelerate with age in patients with schizophrenia: a cross-sectional analysis. Schizophr Bull (2003) 0.78
Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology (2009) 0.78
Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder. Compr Psychiatry (2010) 0.77
The influence of amphetamine on language activation: an fMRI study. Psychopharmacology (Berl) (2005) 0.77
Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. J Clin Psychiatry (2005) 0.77
Neurological signs in parents of schizophrenic patients. Neuroreport (2002) 0.77
An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.77
Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology (Berl) (2004) 0.77